News & Events

You are here

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial competition within Asia is of benefit to sponsors. 


Novotech Update: Three clinical trial and regulatory updates you need to know for your next clinical trial

FDA agrees to IRB Waivers for Minimal Risk Studies 
The FDA recently issued new guidance ...


ARCS 2017: Australia plays a key role in bringing clinical research to Asia, says Novotech

During a panel discussion at this year’s ARCS 2017, Novotech CEO Dr John Moller discussed Australia’s role as a clinical trials gateway into Asia and the important role Australia can play in growing this regional opportunity. 

“Asia is an...


Novotech Update: Novotech shares the importance of good clinical trial project management with Taiwanese biotech companies

Novotech recently delivered an educational workshop on the importance of ‘Timeline Management and Project Tracking’ at an event held by Taiwan’s Development Centre of Biotechnology



NZACRes 2017: Novotech outlines opportunities for New Zealand to increase clinical trial competitiveness

Presenting at NZACRes 2017, Novotech warned New Zealand must continue to invest in areas where it has existing advantages or structural potential, if it is to continue to maintain its leading research position.



CentreWatch Weekly covers Novotech's rapid growth in South Korea

In a front page article, leading US clinical trials CentreWatch Weekly magazine interviews Novotech CEO Dr John Moller on the company's rapid growth in South Korea. 


노보텍, 세브란스 병원 및 SCI-Consortium 과 업무 협약 체결

 노보텍, 세브란스 병원 및 SCI-Consortium 과 업무 협약 체결

2017년 7월 31일, 호주 시드니, 대한민국 서울:

아시아태평양 전문 임상시험수탁기관(CRO) 노보텍은 세브란스병원 및 SCI-...


Novotech signs MOU with South Korea’s SCI-Consortium and Severance Hospital

31 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea’s SCI-Consortium of Clinical Trial Centers...


Novotech Update: South Korea to cover standard of care for patients participating in clinical trials

In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover the cost of standard of care (SOC) for patients participating in clinical trials ...


Novotech Update: India streamlines clinical trial approval process and reduces regulatory timelines

While India is home to almost 17% of the world’s population and 20% of its disease burden, it has one of the lowest clinical trial densities in the world; and while this ratio is not unexpected given its population size, India’s clinical trial...


Novotech launches new site management organisation (SMO) business in South Korea

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include clinical trial site management organisation (SMO)...